Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Diagnostic Codes

ICD-10 Code A94: Unspecified arthropod-borne viral fever

Key Takeaways

Key Takeaways

ICD-10 Code A94 describes unspecified arthropod-borne viral fever, used when the specific arboviral pathogen cannot be identified.

A94 is a valid, billable ICD-10-CM code for fiscal year 2026, with inclusion terms covering arboviral fever NOS and arbovirus infection NOS.

Before assigning A94, coders must rule out more specific codes in the A90-A93 range; A94 is a last-resort code when the pathogen is genuinely unknown.

Practice management software like Pabau supports accurate arboviral diagnosis coding workflows, reducing documentation errors and claim denials.

ICD-10 Code A94 covers unspecified arthropod-borne viral fever, the diagnosis coders assign when a patient has an arthropod-borne fever but lab results don’t confirm the specific virus. It belongs to the family of arboviral diseases classified in the A90-A99 block, and it’s the fever ICD-10 code coders use when the pathogen stays unknown at the time of coding.

ICD-10 Code A94: Definition and clinical description

ICD-10 Code A94 is the official WHO ICD-10 classification for “Unspecified arthropod-borne viral fever.” It’s the arboviral fever ICD-10 code. It sits within Chapter I (Certain infectious and parasitic diseases, A00-B99), specifically the A90-A99 block covering arthropod-borne viral fevers and viral hemorrhagic fevers. The A94 ICD-10 code is billable and valid for FY2026 under ICD-10-CM.

Inclusion terms and NOS designations

Two inclusion terms apply to A94. Coders may use this code when the documentation supports either designation.

  • Arboviral fever NOS (Not Otherwise Specified): the patient has a fever attributable to an arboviral infection, but no specific virus is identified in documentation or lab results.
  • Arbovirus infection NOS: a confirmed or clinically suspected arbovirus infection where the specific pathogen cannot be classified to a more precise code in the A90-A93 range.

The NOS designation is the key signal. It means the provider documented an arboviral etiology but lacked the specificity to assign dengue (A90/A91), West Nile fever (A92.3), or another named arboviral code. The same logic governs other unspecified presentations across ICD-10-CM, such as J40 for bronchitis not specified as acute or chronic.

Classification hierarchy and code placement

Understanding where A94 sits in the ICD-10-CM structure helps coders apply it correctly and avoid sequencing errors.

Level Code/Range Description
Chapter A00-B99 Certain infectious and parasitic diseases
Block A90-A99 Arthropod-borne viral fevers and viral hemorrhagic fevers
Code A94 Unspecified arthropod-borne viral fever
Billable Yes (FY2026) Valid for principal or secondary diagnosis submission
DRG mapping DRG 865 / DRG 866 Viral illness with MCC / Viral illness without MCC

A94 has no subclassifications. It is a terminal code with no further specificity available within ICD-10-CM.

According to the CMS ICD-10 codes page, A94 maps to DRG 865 (Viral illness with major complication or comorbidity) or DRG 866 (Viral illness without MCC). This mapping falls under the CMS ICD-10-CM/PCS MS-DRG v43.0 Definitions Manual for FY2026, with v43.1 applying to discharges on or after April 1, 2026.

Adjacent codes in the A90-A99 range

The A90-A99 block is tightly defined. Each code in the range targets a specific arboviral pathogen or clinical syndrome. Coders must exhaust the more specific codes before assigning A94, the same specificity-first rule that applies to M47.9 in the musculoskeletal chapter.

Code Description Notes
A90 Dengue fever Use when dengue is confirmed without hemorrhagic features
A91 Dengue hemorrhagic fever Dengue with thrombocytopenia and hemorrhagic manifestations
A92 Other mosquito-borne viral fevers Includes Chikungunya (A92.0), Zika (A92.5), West Nile fever (A92.3)
A93 Other arthropod-borne viral fevers Includes Oropouche fever (A93.0), Colorado tick fever (A93.2)
A94 Unspecified arthropod-borne viral fever Assign only when pathogen cannot be determined
A95 Yellow fever Sylvatic (A95.0), Urban (A95.1), Unspecified (A95.9)
A96 Arenaviral hemorrhagic fever Includes Lassa fever (A96.2)
A99 Unspecified viral hemorrhagic fever For hemorrhagic presentations, see A99

The distinction between A94 and A99 trips up many coders. A94 applies to febrile arboviral illness without hemorrhagic features. A99 applies when hemorrhagic manifestations are present but the specific causative virus is unknown. When the clinical picture includes both fever and bleeding, review the documentation carefully before selecting between these two unspecified codes.

Good clinical documentation practices require providers to capture hemorrhagic features explicitly so coders don’t have to guess.

Pro Tip

Run the A90-A93 codes before assigning A94. If a patient returned from a dengue-endemic region with positive NS1 antigen or IgM serology, A90 is correct regardless of the severity level. A94 applies only when serology and PCR results are genuinely inconclusive or pending at the time of claim submission.

Clinical documentation requirements for ICD-10 Code A94

Claim denials for A94 most often trace back to insufficient documentation. Payers expect the medical record to support both the arboviral etiology and the unspecified nature of the pathogen.

What the provider note must capture

  • Exposure history: travel to or residence in an arboviral-endemic region, or confirmed arthropod (mosquito, tick, sandfly) exposure.
  • Clinical presentation: fever with onset consistent with the incubation period for arboviral illness, plus any associated symptoms (myalgia, rash, arthralgia).
  • Diagnostic workup attempted: documentation that specific arboviral serology or PCR was ordered or considered, with results pending, negative, or inconclusive.
  • Reasoning for unspecified code: a note explaining why a more specific code (dengue, Chikungunya, Zika, etc.) was not assigned is best practice, though not universally required by payers.

Structured patient record documentation in a clinical system that supports SOAP-style notes makes capturing these elements far more consistent across providers. Without a structured template, travel history in particular gets buried in free-text fields and becomes invisible to coders.

Comprehensive EMR and patient record management
Comprehensive EMR and patient record management

Timing of code assignment

A94 may be assigned at the time of the encounter even when lab results are pending, provided the clinician documents a working diagnosis of arboviral fever NOS. If subsequent results confirm a specific pathogen, the code should be updated before final claim submission. Retrospective code changes must follow your facility’s query and amendment policies.

The CDC/NCHS ICD-10-CM web tool confirms that A94 carries no instructional notes requiring a code-first or use-additional-code convention. It stands as a standalone principal or secondary diagnosis code without mandatory paired coding.

Reduce coding errors across your infectious disease encounters

Pabau's claims management tools help clinical teams document arboviral encounters accurately from the first visit, so coders get the right information to assign A94 or a more specific code without chasing missing lab notes.

Pabau claims management dashboard

Sequencing rules and coding conventions for A94

A94 has no mandatory sequencing notes in the ICD-10-CM tabular list, but standard sequencing conventions still govern how it interacts with complication and comorbidity codes that ultimately feed into revenue cycle management.

A94 as principal diagnosis

When unspecified arboviral fever is the condition chiefly responsible for the admission or outpatient encounter, A94 sequences first. This is the common scenario in travel medicine clinics, infectious disease consultations, and urgent care settings where the patient presents with fever of recent onset following travel.

A94 as secondary diagnosis

When the patient is admitted primarily for another condition and arboviral fever is identified as a comorbidity or complication, A94 sequences as a secondary code. Document the clinical relationship between A94 and the principal diagnosis clearly in the provider note to support medical necessity.

Complication and symptom coding

Symptoms integral to A94 (fever, myalgia, arthralgia, headache) are not coded separately per ICD-10-CM conventions. Code additional manifestations only when they are not routinely associated with the arboviral fever syndrome, or when they are clinically significant enough to affect patient management independently, such as post-viral CNS complications reported under G09.

Maintaining compliance management workflows across your coding team helps ensure these sequencing decisions are applied consistently, particularly when multiple coders handle infectious disease encounters.

HIPAA compliance in Pabau
HIPAA compliance in Pabau

Pro Tip

When a patient with A94 develops thrombocytopenia during the encounter, code the thrombocytopenia separately (D69.6 or the most specific subcode) only if it is clinically managed as a distinct problem. If it resolves with the arboviral fever and required no separate intervention, it is integral to A94 and should not be separately coded.

Billing guidance and payer considerations for arboviral fever coding

Arboviral fever encounters cluster in specific clinical settings: travel medicine, urgent care, infectious disease, and emergency departments. Each setting carries slightly different payer expectations for supporting documentation.

Outpatient billing

For outpatient encounters, such as those in primary care or urgent care, A94 must be reported as a confirmed diagnosis when that’s how the provider documented it. If the provider wrote “rule out arboviral fever” or “suspected arbovirus,” code the presenting signs and symptoms instead (fever, myalgia, etc.) per outpatient coding guidelines.

Reserve A94 for encounters where the provider states a definitive or working diagnosis of arboviral illness.

Inpatient billing

Inpatient guidelines allow coders to assign A94 based on a working or probable diagnosis documented at discharge. The UHDDS definition of principal diagnosis applies: the condition established after study to be chiefly responsible for the admission. If the patient was admitted with “probable arboviral fever” and discharged with that diagnosis unchanged, A94 is appropriate as the principal code.

Medical necessity and prior authorization

Some payers may require prior authorization for infectious disease hospitalizations. A94 alone rarely triggers a coverage issue, but supporting documentation should demonstrate the clinical rationale for the level of care provided. The AAPC Codify ICD-10-CM lookup notes no specific coverage restrictions for A94 at a national level, though local coverage determinations (LCDs) vary by MAC jurisdiction.

Practices using claims management software with built-in code validation can flag A94 claims for documentation completeness before submission, reducing the likelihood of a payer query or denial on the basis of insufficient specificity.

Automate claims and billing with Pabau
Automate claims and billing with Pabau

A94 in the context of travel medicine and public health reporting

Arboviral fevers are reportable conditions in most US states and many international jurisdictions. When A94 is assigned, clinical teams should confirm whether local or state public health reporting requirements apply, regardless of the billing code used.

Travel medicine clinics frequently encounter patients who return from endemic regions with febrile illness before a specific arboviral diagnosis can be confirmed. In these encounters, A94 serves a dual function: it enables billing for the clinical encounter while the laboratory workup proceeds, and it flags the case in administrative data systems used for surveillance.

Using digital intake forms that capture travel history, recent arthropod exposure, and vaccination status at registration gives providers the clinical context they need to document arboviral exposure properly before the encounter begins. This reduces the chance that A94 is assigned when a more specific code would have been appropriate with better upfront data collection.

Customizable consent and intake forms
Customizable consent and intake forms

Maintaining HIPAA-compliant documentation practices is also relevant here. Arboviral illness records often feed into public health surveillance systems, and the exchange of coded encounter data between providers and health departments must follow applicable data privacy rules. Practices should verify that their EHR data-sharing agreements cover public health reporting workflows.

For coders managing high volumes of travel medicine encounters, staying current with your facility’s coding department, AAPC membership updates, and AI clinical documentation tools keeps your team aligned with any changes to the A90-A99 code block. The patient intake documentation process is the first link in the coding chain, and strengthening it has a direct impact on code specificity downstream.

Conclusion

Coders regularly assign A94 when arboviral exposure is clear but the specific pathogen is not. The risk is under-specificity: reaching for A94 before exhausting dengue, Chikungunya, Zika, and the other named codes in A90-A93. When documentation supports a named arbovirus, the more specific code always takes precedence.

Pabau’s claims management software helps infectious disease and travel medicine practices structure their documentation workflows so the right clinical detail reaches the coder at submission time. This reduces A94 over-use and supports accurate ICD-10 coding across arboviral encounters. To see how Pabau handles this, book a demo.

Continue your research

Continue your research

Need to compare A94 with its neighboring hemorrhagic fever code? A99 covers unspecified presentations with hemorrhagic features, helping you distinguish between the two unspecified codes in the A90-A99 block.

Looking to tighten up your infectious disease documentation workflows? Our guide to patient data security tools covers how to protect sensitive encounter data while meeting public health reporting obligations.

Want to reduce claim denials across your practice? Our roundup of the best EMR software options evaluates platforms that combine robust ICD-10 coding support with built-in claim validation.

Frequently asked questions

What is ICD-10 Code A94?

ICD-10 Code A94 is a billable diagnosis code for “Unspecified arthropod-borne viral fever,” used when a patient has a fever linked to an arboviral infection but the specific pathogen cannot be identified from clinical documentation or laboratory results. It includes the inclusion terms arboviral fever NOS and arbovirus infection NOS.

Is ICD-10 Code A94 valid for 2026?

Yes. A94 is a valid, billable ICD-10-CM diagnosis code for fiscal year 2026. It has been a valid billable code continuously since at least 2016 and remains active in the current tabular list maintained by CDC/NCHS.

When should I use A94 instead of A90 or A92?

Use A94 only when serology, PCR, and clinical findings cannot confirm a specific arbovirus. If dengue serology is positive, assign A90 or A91. If Chikungunya, Zika, or West Nile is confirmed, assign the appropriate A92 subcode. A94 is a last-resort code when the pathogen genuinely cannot be determined at the time of coding.

What DRG does A94 map to?

A94 maps to DRG 865 (Viral illness with major complication or comorbidity) or DRG 866 (Viral illness without MCC) under the CMS ICD-10-CM/PCS MS-DRG v43.0 Definitions Manual for FY2026 (v43.1 applies for discharges on or after April 1, 2026). The specific DRG assignment depends on the presence or absence of a qualifying MCC in the rest of the claim.

Can A94 be assigned for a suspected or probable arboviral fever diagnosis?

For inpatient encounters, yes. Inpatient coding guidelines permit assignment of A94 based on a probable or working diagnosis documented at discharge. For outpatient encounters, code the presenting signs and symptoms instead unless the provider explicitly states a confirmed or definitive diagnosis of arboviral fever.

×